Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedA new Revision: v3.6.4 tag appears in the record history, replacing the prior v3.6.3. This indicates a minor platform update to the history page rather than changes to study data or content.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded a new 'Study Status' entry to the record history on 2026-07-17 (associated with the value 60). Removed the 2026-06-30 entry.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry (v3.6.3) appears in the history on 2026-06-30 with an added Study Status label; the prior revision (v3.6.2) from 2026-05-19 was removed.SummaryDifference0.3%

- Check30 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and an older revision (v3.6.0) was removed from the history, indicating an update to the record's version history.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study history now shows recruitment has ended and the latest revision tag is v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now shows Revision: v3.5.5, indicating an updated version of the page; the previous Revision: v3.5.4 label has been removed.SummaryDifference0.1%

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.